期刊文献+

细菌脂多糖免疫对炎症性肠病小鼠肿瘤坏死因子-α表达的影响 被引量:3

Influence of bacterial lipopolysaccharide immune on the expression of tumor necrosis factor-αin mice with inflammatory bowel disease
原文传递
导出
摘要 目的探讨细菌脂多糖免疫对炎症性肠病小鼠肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)表达的影响及其作用机制。方法 BALB/C雌性小鼠10只随机分为实验组5只和对照组5只,实验组腹腔内注射1.0mg/kg细菌脂多糖和免疫佐剂的混合物,对照组腹腔内注射免疫佐剂1.0mg/kg,2组小鼠均每周注射1次,注射4次。末次注射1周后均给予150mg/kg的三硝基苯磺酸乙醇溶液灌肠诱导炎症性肠病。观察2组小鼠一般状态、体质量改变情况、粪便性状,检测粪便隐血;灌肠1周后处死小鼠,观察结肠组织学改变,采用ELISA法检测结肠组织TNF-α表达情况,采用Western blot法检测结肠组织核因子(nuclear factor,NF)-κB表达情况。结果 2组小鼠灌肠后第2天均出现懒动、厌食、皮毛凌乱、腹泻,第3天出现血便、体质量下降,实验组上述表现较对照组轻,恢复快;实验组小鼠第3天体质量下降克数((1.60±0.38)g)、粪便隐血阳性持续时间((2.40±0.54)d)、结肠组织学评分((3.72±2.45)分)、结肠组织TNF-α表达水平((20.16±3.21)ng/L)和NF-κB吸光度值((18.43±5.36)×10-3)均明显低于对照组((2.80±0.45)g、(3.60±0.46)d、(6.39±1.72)分、(32.35±2.80)ng/L、(25.80±3.79)×10-3)(P<0.05)。结论细菌脂多糖免疫可降低炎症性肠病小鼠结肠组织TNF-α和NF-κB表达水平,减轻结肠组织病理损伤,机体对细菌脂多糖反应异常可能是炎症性肠病的发病因素之一。 Objective To investigate the effects of bacterial lipopolysaccharide immune on the expression of tumor necrosis factor-α(TNF-α)and its mechanism in mice with inflammatory bowel disease.Methods Ten BALB/C mice were randomly divided into experimental group and control group,with 5 mice in each group.Experiment group received intraperitoneal injection of 1.0 mg/kg bacterial lipopolysaccharide immunologic adjuvant mixtures once a week.Control group only received intraperitoneal injection of 1.0 mg/kg immunologic adjuvant.Both groups were given injection for four times.The inflammatory bowel disease was induced by clysis with 150 mg/kg trinitro-benzene-sulfonic acid in ethanol solution one week after the last injection.The general status,the change of body mass,and fecal features of mice were observed in both groups.The fecal occult blood was tested.The mice were sacrificed one week after clysis.The histological changes in the colon were evaluated by HE staining.The expression of TNF-αin the colonic tissue was detected by ELISA,and the expression of NF-κB was detected by Western blot.Results Both two groups showed accidie,inappetence,messy fur and diarrhea on the second day after clysis,followed by bloody stools and body mass loss on the third day,which were milder and recovered more quickly in experiment group in comparison with control group.On the third day,the body mass loss,the duration of positive fecal occult blood,the histopathologic score of colon,the level of TNF-α,and the level of NF-κB were(1.60±0.38)g,(2.40±0.54)days,3.72±2.45,(20.16±3.21)ng/L and(18.43±5.36)×10^-3 in experiment group,significantly lower than those in control group((2.80±0.45)g,(3.60±0.46)days,6.39±1.72,(32.35±2.80)ng/L,(25.80±3.79)×10^-3)(P〈0.05).Conclusion The bacterial lipopolysaccharide immune can decrease the expressions of TNF-αand NF-κB and reduce the pathological damage to the colonic tissue in mice with inflammatory bowel disease. The abnormal reaction of the body against bacterial lipopolysaccharide may be one of the pathogenic factors of inflammatory bowel disease.
出处 《中华实用诊断与治疗杂志》 2015年第1期28-30,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 大连市卫生局基金(2013192)
关键词 细菌脂多糖 炎症性肠病 肿瘤坏死因子-Α 核因子-ΚB Lipopolysaccharide inflammatory bowel disease tumor necrosis factor-α nuclear factor-κB
  • 相关文献

参考文献12

  • 1Xavier RJ, Podolsky DK. Unravealing the pathogenesis ofinflammatory bowel disease[J]. Nature, 2010, 448(7152) : 427-434.
  • 2魏谋,唐娟,林惠梅,罗晓玲,周伟.革兰阴性菌感染新生儿血浆脂多糖测定临床意义[J].中华实用诊断与治疗杂志,2013,27(6):623-624. 被引量:6
  • 3Xu D,Yu H,Yu Q, et al. Salvia miltiorrhiza increases theexpression of transcription factor Foxp3 in experimental murinecolitis[J], Mol Med Rep,2014,9(5) : 1947-1951.
  • 4朱峰,钱家鸣,潘国宗.细胞免疫反应性炎症性肠病动物模型的建立[J].中国医学科学院学报,1998,20(4):271-278. 被引量:79
  • 5刘东屏,陶春梅,张艳梅,王学梅.63例炎症性肠病经腹超声检查与结肠镜的对比分析[J].实用诊断与治疗杂志,2008,22(3):177-179. 被引量:8
  • 6刘振邦,周薇,胡石奇,梁立源.炎症性肠病患者生存质量及其影响因素的调查[J].中华全科医学,2011,9(1):90-92. 被引量:18
  • 7Takaishi H,Matsuki T, Nakazawa A, et al. Imbalance inintestinal microflora constitution could be involved in thepathogenesis of inflammatory bowel disease [J]. Int J MedMicrobiol,2008,298(5/6) :463-472.
  • 8Taurog JD, Richardson JA, Croft JT, et al. The germfree stateprevents development of gut and joint inflammatory disease inHLA-B27 transgenic rats[J]. J Exp Med* 1994? 180( 6> : 2359-2364.
  • 9Klement E,Lysy J, Hoshen M, et al. Childhood hygiene isassociated with the risk for inflammatory bowel disease: apopulation-based study[J]. Am J Gastroenterol, 2008? 103(7):1775-1782.
  • 10Poltorak A, He X,Smirnova I,et al. Defective LPS signalingin C3H / He J and C57BL/10 ScCr mice: mutations in Tlr4gene[J]. Science,1998,282(4):2085-2088.

二级参考文献25

  • 1周平安,杜海军,林礼务.超声造影技术应用新进展[J].延安大学学报(医学科学版),2006,4(4):6-7. 被引量:3
  • 2欧阳钦.我国炎症性肠病研究的概况和策略[J].四川医学,2005,26(4):355-356. 被引量:12
  • 3何英,季秀珍,万志龙,张建兵.经直肠超声诊断直肠肿瘤与病理对照分析[J].中国超声诊断杂志,2005,6(11):866-867. 被引量:4
  • 4马桂英,袁建军.浅谈超声误诊原因与防范[J].实用诊断与治疗杂志,2006,20(4):279-280. 被引量:19
  • 5柳伟,洪斌.超声显像诊断大肠癌128例分析[J].中国误诊学杂志,2006,6(16):3159-3159. 被引量:5
  • 6Dianne S, Robert T. Coping methods of patients with inflammatory bowel disease and prediction of perceived health, functional status, and well-being[ J ]. Gastroenterol Nuts, 1998,21 ( 3 ) : 112-118.
  • 7Sands BE. From symptom to diagnosis : clinical distinctions among various forms of intestinal inflammation [ J ]. Gastroenterology, 2004,126 (6) :1518-1532.
  • 8Grenth J, Torok HP, Koenig A, et al. Comparison of inflammatory bowel disease at younger and older age [ J ]. Eur J Med Res, 2004,9 (12) : 552-554.
  • 9Casellas F,Aleala MJ,Prieto L, et al. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire [ J ]. Am J Gastroenterol, 2004, 99(3) :457-461.
  • 10Hjortswang H, Jarnerot G, Curman B, et al. The influence of demographic and disease-related factors on health-related quality of life in patients with ulcerative colitis[ J ]. Eur J Gastroenterol Hepatol,2003, 15(9) :1011-1020.

共引文献107

同被引文献36

  • 1王飞,贺蓓.难辨梭状芽孢杆菌相关性腹泻暴发流行的调查[J].中华医学杂志,2006,86(6):432-432. 被引量:9
  • 2冀勇,王志刚,丁璇,曲春城,张庆林.兔蛛网膜下腔出血后NF-κB在基底动脉的表达[J].中华神经外科杂志,2007,23(10):780-782. 被引量:8
  • 3Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantationEJ. Clin Gastroenterol Hepatol, 2011,9 (12) : 1044 1049.
  • 4Di Bella S, Drapeau C, Garcia Almod6var E, et al. Fecal microbiota transplantation: the state o{ the artEJ. Infect Dis Rep,2013,5(2) 43-45.
  • 5Eiseman B, Silen W, Bascom GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitisEJ]. Surgery, 1958,1 (44) 854-859.
  • 6Collins DA, Hawkey PM, Riley TV. Epiderniology o{ Clostridiura difficile in{ection in Asia [J]. Antimicrob Resist Infect Control,2013,2(1) 21.
  • 7. Surawicz CM, Brandt LJ, Binion DG. Guidelines {or diagnosis, treatment, and prevention o{ Clostridium difficile inectionsEJ]. Am l Gastroentero/,2013,499(108) 478 498.
  • 8Borody TJ, Khoruts A. Fecal microbiota transplantation andemerging a pplicationgsEJ]. Nat Rev Gastroenterol Hepatol, 2011,9(2) :88-96.
  • 9Bennet JD, Brinkman M. Treatment o{ ulcerative colitis byimplantation of normal coloninc flora[J]. Lancet, 1989, 1 (8630) 164.
  • 10Gough E, Skaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infectionJ. Clin Infect Dis, 2011,53(10) ..994 1002.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部